Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (201-210 of 308) with videos related to

Pageof 31
Sort By:
Thrombosis and Haemostasis|July 29, 2025
Time Trends in Cause-specific Mortality in Patients with Pulmonary Embolism Aged 50 Years and OlderKatarina Glise Sandblad, Kristina Svennerholm, Jacob Philipson, et al.
Current Medical Research and Opinion|September 14, 2006
Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjectsJohan Wemer, Yi-Fang Cheng, Dag Nilsson, et al.
Journal of the American Heart Association|September 24, 2020
Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation StudyAlfonso J Tafur, Nathan P Clark, Alex C Spyropoulos, et al.
Plos One|February 14, 2014
Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulantsLuciane Cruz Lopes, Frederick A Spencer, Ignacio Neumann, et al.
Journal of Thrombosis and Haemostasis : JTH|July 29, 2022
Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTHAlex C Spyropoulos, Jean M Connors, James D Douketis, et al.
Thrombosis Research|February 25, 2016
Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding eventsAmmar Majeed, Hun-Gyu Hwang, John W Eikelboom, et al.
Journal of Thrombosis and Thrombolysis|August 28, 2021
Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE studySamuel Z Goldhaber, Walter Ageno, Ivan B Casella, et al.
The New England Journal of Medicine|February 22, 2013
Extended use of dabigatran, warfarin, or placebo in venous thromboembolismSam Schulman, Clive Kearon, Ajay K Kakkar, et al.
Thrombosis and Haemostasis|September 26, 2015
Bleeding events with dabigatran or warfarin in patients with venous thromboembolismAmmar Majeed, Samuel Z Goldhaber, Ajay Kakkar, et al.
Blood Advances|August 7, 2020
Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedureJoseph R Shaw, Na Li, Thomas Vanassche, et al.
Pageof 31

Showing results (201-210 of 308) with videos related to

Sort By:
Pageof 31
Thrombosis and Haemostasis|July 29, 2025
Time Trends in Cause-specific Mortality in Patients with Pulmonary Embolism Aged 50 Years and OlderKatarina Glise Sandblad, Kristina Svennerholm, Jacob Philipson, et al.
Current Medical Research and Opinion|September 14, 2006
Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjectsJohan Wemer, Yi-Fang Cheng, Dag Nilsson, et al.
Journal of the American Heart Association|September 24, 2020
Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation StudyAlfonso J Tafur, Nathan P Clark, Alex C Spyropoulos, et al.
Plos One|February 14, 2014
Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulantsLuciane Cruz Lopes, Frederick A Spencer, Ignacio Neumann, et al.
Journal of Thrombosis and Haemostasis : JTH|July 29, 2022
Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTHAlex C Spyropoulos, Jean M Connors, James D Douketis, et al.
Thrombosis Research|February 25, 2016
Effectiveness and outcome of management strategies for dabigatran- or warfarin-related major bleeding eventsAmmar Majeed, Hun-Gyu Hwang, John W Eikelboom, et al.
Journal of Thrombosis and Thrombolysis|August 28, 2021
Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE studySamuel Z Goldhaber, Walter Ageno, Ivan B Casella, et al.
The New England Journal of Medicine|February 22, 2013
Extended use of dabigatran, warfarin, or placebo in venous thromboembolismSam Schulman, Clive Kearon, Ajay K Kakkar, et al.
Thrombosis and Haemostasis|September 26, 2015
Bleeding events with dabigatran or warfarin in patients with venous thromboembolismAmmar Majeed, Samuel Z Goldhaber, Ajay Kakkar, et al.
Blood Advances|August 7, 2020
Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedureJoseph R Shaw, Na Li, Thomas Vanassche, et al.
Pageof 31